![](/img/cover-not-exists.png)
Immunotherapeutic options for management of relapsed or refractory B-cell acute lymphoblastic leukemia: how to select newly approved agents?
Dhakal, Prajwal, Kaur, Jasleen, Gundabolu, Krishna, Raj Bhatt, VijayaLanguage:
english
Journal:
Leukemia & Lymphoma
DOI:
10.1080/10428194.2019.1641802
Date:
July, 2019
File:
PDF, 1.19 MB
english, 2019